Neurology/Neuromuscular

REACH is an experienced thought leader in the neurology/neuromuscular space. Our team has conducted research across many neurological and neuromuscular diseases, both rare and non-rare.

DISEASES WE COVER

The rare neurology and neuromuscular treatment landscape is rapidly transforming with the emergence of innovative disease-modifying technologies, such as gene therapy and RNA-based therapies. Our team is tracking several factors in this therapy area that we expect to significantly influence treatment and market dynamics including:

  • The shortage of neurologists
  • Continued drug development focus on gene and antisense oligonucleotide therapies
  • Regulatory guidance and accelerated drug approvals based on biomarkers in slowly progressive neurological diseases (e.g., Duchenne Muscular Dystrophy, Alzheimer’s disease)
See our rare neurology solutions

Search Neurology diseases we cover



Browse contacts:
1 2 3 12

Schedule a neurology demo with our team

OUR SOLUTIONS

Market Landscape Assessment

MarketVue® reports capture the current and anticipated future state of any rare neurology/neuromuscular market

Learn More

Epidemiology

EpiVue® reports quantify prevalence, diagnosis, treatment rates and patient segments for rare neurological conditions

Learn More

Indication Prioritization

MarketSheet® single-sheet market primers for any neurology disease allow easy comparison across the neurology therapy area

Learn More

Custom Rapid Insights

Fast turnaround primary market research for a focused set of questions for neurologists or payers

Learn More

Reach out to our team to learn more about our capabilities and view sample reports.

Contact us